Related Article

This Commentary refers to the following article:
Chemoprevention of Head and Neck Cancer with Celecoxib and Erlotinib: Results of a Phase Ib and Pharmacokinetic Study
Nabil F. Saba, Selwyn J. Hurwitz, Scott A. Kono, Chung S. Yang, Yang Zhao, Zhengjia Chen, Gabe Sica, Susan M�ller, Rachel Moreno-Williams, Melinda Lewis, William Grist, Amy Y. Chen, Charles E. Moore, Taofeek K. Owonikoko, Suresh Ramalingam, Jonathan J. Beitler, Sreenivas Nannapaneni, Hyung Ju C. Shin, Jennifer R. Grandis, Fadlo R. Khuri, Zhuo Georgia Chen, and Dong M. Shin